Skip to main content
Premium Trial:

Request an Annual Quote

IncellDx Inks Dx Distribution Deal in India

NEW YORK (GenomeWeb) – Premas Life Sciences announced today that it has signed an agreement to acquire the exclusive distribution rights in India to IncellDx's portfolio of immune-oncology and oncology diagnostic products.

Included in the deal are IncellDx's OncoTect single-cell assay for quantifying PD-L1 on tumor cells and immune cell subtypes; its single-cell assay for HPV E6/E7 mRNA detection in cervical samples; and its IncellPrep single-cell preparation kit for solid tissues including tumors.

Additional terms were not disclosed.

"IncellDx's OncoTect assays ... offer revolutionary single-cell proteomic and genomics marker-based diagnostics and, more importantly, a prognostic solution for early detection and staging for cancer patients with more targeted immuno-onco therapies," Premas Managing Director Praveen Gupta said in a statement. "India's cancer burden is increasing, and IncellDx offers a perfect path for highly effective companion diagnostics."

Late last year, IncellDx inked a deal for the Chinese distribution rights to its products with GIMDx. Earlier this year, it partnered with Celsee on the commercialization of several diagnostic products including a 20-marker lung cancer genomics and proteomics panel and a cell-based NIPT assay.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.